celiprolol has been researched along with Arrhythmia in 1 studies
Celiprolol: A cardioselective beta-1 adrenergic antagonist that has intrinsic sympathomimetic activity. It is used in the management of ANGINA PECTORIS and HYPERTENSION.
| Excerpt | Relevance | Reference |
|---|---|---|
| "In a randomized trial the effect was studied of celiprolol, a cardioselective beta receptor blocker with strong intrinsic activity (ISA) on the incidence of ventricular arrhythmias in patients with acute myocardial infarction (AMI)." | 5.06 | [Celiprolol in acute myocardial infarct]. ( Kratzer, H; Kühn, P; Payrhuber, K, 1986) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Payrhuber, K | 1 |
| Kratzer, H | 1 |
| Kühn, P | 1 |
1 trial available for celiprolol and Arrhythmia
| Article | Year |
|---|---|
[Celiprolol in acute myocardial infarct].
Topics: Administration, Oral; Adrenergic beta-Antagonists; Adult; Aged; Arrhythmias, Cardiac; Celiprolol; Cr | 1986 |